geodon
Generic: ziprasidone
Labeler: viatris specialty llcDrug Facts
Product Profile
Brand Name
geodon
Generic Name
ziprasidone
Labeler
viatris specialty llc
Dosage Form
CAPSULE
Routes
Active Ingredients
ziprasidone 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
58151-131
Product ID
58151-131_a2b4cc65-6a6d-49c4-adfc-a4458562a167
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020825
Listing Expiration
2026-12-31
Marketing Start
2025-09-09
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
58151131
Hyphenated Format
58151-131
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
geodon (source: ndc)
Generic Name
ziprasidone (source: ndc)
Application Number
NDA020825 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING GEODON capsules are differentiated by capsule color/size and are imprinted in black ink with “VTRS and ZDX [dosage strength]”. GEODON capsules are supplied for oral administration in 20 mg (blue/white), 40 mg (blue/blue), 60 mg (white/white), and 80 mg (blue/white) capsules. They are supplied in the following strengths and package configurations: GEODON Capsules Package Configuration Capsule Strength (mg) NDC (National Drug Code) Imprint Bottles of 60 20 58151-131-91 “VTRS” on the cap and “ZDX 20” on the body Bottles of 60 40 58151-132-91 “VTRS” on the cap and “ZDX 40” on the body Bottles of 60 60 58151-133-91 “VTRS” on the cap and “ZDX 60” on the body Bottles of 60 80 58151-134-91 “VTRS” on the cap and “ZDX 80” on the body GEODON capsules should be stored at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. GEODON for Injection is available in a single-dose vial as ziprasidone mesylate (20 mg ziprasidone/mL when reconstituted according to label instructions) [see Dosage and Administration (2.4) ] . Each mL of ziprasidone mesylate for injection (when reconstituted) affords a colorless to pale pink solution that contains 20 mg of ziprasidone and 4.7 mg of methanesulfonic acid solubilized by 294 mg of sulfobutylether β-cyclodextrin sodium (SBECD). GEODON for Injection Package Concentration NDC Single-dose Vials (carton of 10 vials) 20 mg/mL 58151-137-81 GEODON for Injection should be stored at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] in dry form. Protect from light. Following reconstitution, GEODON for Injection can be stored, when protected from light, for up to 24 hours at 15°C to 30°C (59°F to 86°F) or up to 7 days refrigerated, 2°C to 8°C (36°F to 46°F).
- PRINCIPAL DISPLAY PANEL – 20 mg NDC 58151-131-91 GEODON ® (ziprasidone) capsules 20 mg* 60 Capsules Rx only Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. DOSAGE AND USE See accompanying prescribing information. * Each capsule contains ziprasidone hydrochloride monohydrate equivalent to 20 mg ziprasidone. Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. Made in Ireland RUPJ131D Geodon 20 mg Container Label
- PRINCIPAL DISPLAY PANEL – 40 mg NDC 58151-132-91 GEODON ® (ziprasidone) capsules 40 mg* 60 Capsules Rx only Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. DOSAGE AND USE See accompanying prescribing information. * Each capsule contains ziprasidone hydrochloride monohydrate equivalent to 40 mg ziprasidone. Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. Made in Ireland RUPJ132D Geodon 40 mg Container Label
- PRINCIPAL DISPLAY PANEL – 60 mg NDC 58151-133-91 GEODON ® (ziprasidone) capsules 60 mg* 60 Capsules Rx only Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. DOSAGE AND USE See accompanying prescribing information. * Each capsule contains ziprasidone hydrochloride monohydrate equivalent to 60 mg ziprasidone. Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. Made in Ireland RUPJ133D Geodon 60 mg Container Label
- PRINCIPAL DISPLAY PANEL – 80 mg NDC 58151-134-91 GEODON ® (ziprasidone) capsules 80 mg* 60 Capsules Rx only Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. DOSAGE AND USE See accompanying prescribing information. * Each capsule contains ziprasidone hydrochloride monohydrate equivalent to 80 mg ziprasidone. Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. Made in Ireland RUPJ134D Geodon 80 mg Container Label
- PRINCIPAL DISPLAY PANEL – 20 mg/mL NDC 58151-137-81 Contains 10 of NDC 58151-137-32 10 Single Dose Vials GEODON ® for Injection (ziprasidone mesylate) equivalent to 20 mg/mL* of ziprasidone PROTECT FROM LIGHT. Sterile For Intramuscular Use Only Rx only Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] in dry form. PROTECT FROM LIGHT. DOSAGE AND USE See accompanying prescribing information. Reconstitute to 20 mg/mL with 1.2 mL of Sterile Water for Injection (only). Shake vigorously until all the drug is dissolved to afford a colorless to pale pink solution. *Each mL (when reconstituted) contains 20 mg of ziprasidone and 4.7 mg of methanesulfonic acid solubilized by 294 mg of sulfobutylether β-cyclodextrin sodium (SBECD). Following reconstitution, GEODON for Injection can be stored, when protected from light, for up to 24 hours at 15°C to 30°C (59°F to 86°F) or up to 7 days refrigerated, 2°C to 8°C (36°F to 46°F). For Intramuscular Use Only Distributed by: Viatris Specialty LLC Morgantown, WV 26505 U.S.A. © 2024 Viatris Inc. GEODON is a registered trademark of Viatris Specialty LLC, a Viatris Company. UPJ:137:1C:R1 Geodon 20 mg/mL Carton Label
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a2b4cc65-6a6d-49c4-adfc-a4458562a167", "openfda": {"nui": ["N0000175430"], "upc": ["0358151134915", "0358151133918", "0358151132911"], "unii": ["3X6SAX83JZ", "6UKA5VEJ6X"], "rxcui": ["284548", "284549", "284550", "285127", "313776", "313777", "313778", "314286", "351223", "352228"], "spl_set_id": ["a2b4cc65-6a6d-49c4-adfc-a4458562a167"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Viatris Specialty LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Geodon", "product_id": "58151-131_a2b4cc65-6a6d-49c4-adfc-a4458562a167", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "58151-131", "generic_name": "ziprasidone", "labeler_name": "Viatris Specialty LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Geodon", "active_ingredients": [{"name": "ZIPRASIDONE", "strength": "20 mg/1"}], "application_number": "NDA020825", "marketing_category": "NDA", "marketing_start_date": "20250909", "listing_expiration_date": "20261231"}